Behavioural Intervention
Oxygen + Finasteride + Acetazolamide for Sleep Apnea in Elderly
This trial is testing three treatments—oxygen, finasteride, and acetazolamide—to help elderly Veterans with sleep apnea. These treatments aim to make breathing more stable during sleep by providing extra oxygen, altering hormone levels, and changing how the body handles carbon dioxide. The goal is to find easier and more effective ways to treat sleep apnea in this group.
Device
Intensive CPAP Support for Stroke Patients with Sleep Apnea
This trial is testing if a program that provides intensive support for using a CPAP machine is more effective than the standard care for stroke patients with sleep apnea during rehabilitation. They will have 250 participants
Behavioural Intervention
Ketone-IQ for Sleep Apnea
This trial aims to test if taking a product called Ketone-IQ before bedtime can improve sleep quality and reduce the severity of obstructive sleep apnea. The researchers believe that ingesting exogenous ket
Behavioural Intervention
Mouth Tape for Snoring and Sleep Apnea
This trial is looking at a new way to treat snoring by promoting nasal breathing instead of mouth breathing during sleep. Snoring can disrupt sleep quality for both the snorer and their bed partner, and
Popular Filters
Trials for Obstructive Sleep Apnea Patients
Procedure
DISE Phenotyping for Obstructive Sleep Apnea
This trial will use DISE to examine the upper airway and determine if there are any obstructions in the airway that could cause problems during sleep. It will also use nasal pressure and CT/ultrasound imaging to help predict success of standard surgical interventions to correct any problems found.
Negative Pressure Device
Negative Pressure Device for Sleep Apnea
This trial tests the aerSleep® II device, which helps people with sleep apnea breathe better at night. It targets adults who can't use the usual CPAP therapy. The device works by keeping the airway open during sleep.
Trials for OSA Patients
Procedure
DISE Phenotyping for Obstructive Sleep Apnea
This trial will use DISE to examine the upper airway and determine if there are any obstructions in the airway that could cause problems during sleep. It will also use nasal pressure and CT/ultrasound imaging to help predict success of standard surgical interventions to correct any problems found.
Negative Pressure Device
Negative Pressure Device for Sleep Apnea
This trial tests the aerSleep® II device, which helps people with sleep apnea breathe better at night. It targets adults who can't use the usual CPAP therapy. The device works by keeping the airway open during sleep.
Trials With No Placebo
Procedure
DISE Phenotyping for Obstructive Sleep Apnea
This trial will use DISE to examine the upper airway and determine if there are any obstructions in the airway that could cause problems during sleep. It will also use nasal pressure and CT/ultrasound imaging to help predict success of standard surgical interventions to correct any problems found.
Behavioral Intervention
Behavioral Education for Sleep Apnea
This trial will test the effects of an education program specifically designed for middle-aged and older Veterans who have stopped using their PAP device, or are not using it regularly, in order to improve sleep, function and quality of life.
Negative Pressure Device
Negative Pressure Device for Sleep Apnea
This trial tests the aerSleep® II device, which helps people with sleep apnea breathe better at night. It targets adults who can't use the usual CPAP therapy. The device works by keeping the airway open during sleep.
View More Related Trials
Frequently Asked Questions
Introduction to sleep apnea
What are the top hospitals conducting sleep apnea research?
[Sleep apnea](https://www.withpower.com/clinical-trials/sleep-apnea), a common yet potentially serious sleep disorder, is being tackled head-on by some of the top hospitals in various locations. In Detroit, the John D. Dingell VA Medical Center has taken up the challenge with four ongoing sleep apnea trials. While it may be relatively new to this area of research, having just initiated its first trial in 2021, their commitment to finding solutions for sleep apnea is highly commendable. Similarly, Brigham and Women's Hospital in Boston has also dedicated itself to combating this condition through four active trials. With their first recorded sleep apnea trial dating back to 2019, they have been at the forefront of research and innovation.
North of the border in Toronto lies Sunnybrook Health Sciences Centre—although they haven't conducted any previous clinical trials on sleep apnea as yet—this institution is currently involved in three ongoing studies regarding this sleep disorder. This emerging focus holds tremendous potential for advancements that could benefit patients worldwide.
In Tucson at the University of Arizona, researchers have been investigating sleep apnea since 2008 when they undertook their inaugural study on this topic. Since then, they have accumulated valuable insights from two completed trials and continue furthering their efforts with three active investigations today.
Meanwhile in sunny San Diego at the University of California San Diego (UCSD), experts are delving into understanding and managing sleep apnea as well; although UCSD's involvement started more recently recorded only two years ago but already contributing significantly by conducting one all-time trial alongside current addressing projects numbering two.
These esteemed institutions spearhead pioneering research endeavors across different regions while aiming towards improving our understanding and treatment options for individuals grappling with this pervasive condition that affects quality of life during waking hours due to disrupted restful nights' slumber . By pushing boundaries and collaborating closely within these clinical settings , there remains hope that breakthroughs will ultimately lead us towards better management strategies thus ensuring improved health outcomes for sleep apnea patients globally.
Which are the best cities for sleep apnea clinical trials?
La Jolla, California, Toronto, Ontario, Philadelphia, Pennsylvania, Detroit, Michigan and Boston Massachusetts are among the best cities for sleep apnea clinical trials. La Jolla leads with 10 active trials focusing on treatments such as Acetazolamide, Supplemental Oxygen and Continuous Positive Airway Pressure (CPAP). Toronto follows closely behind with 8 ongoing studies evaluating Home Sleep Apnea Tests and CPAP therapy. Philadelphia also has 8 active trials investigating interventions like CPAP and Drug-Induced Sleep Endoscopy. Similarly, Detroit's 8 active trials explore treatments including CPAP and supplemental oxygen. Lastly, Boston offers 8 studies covering a range of interventions like Oxybutynin and the Genio™ system. These cities provide valuable opportunities for individuals with sleep apnea to participate in research that could lead to improved care options in the future.
Which are the top treatments for sleep apnea being explored in clinical trials?
Clinical trials are shedding light on the top treatments for sleep apnea, with acetazolamide emerging as a promising contender. Currently involved in three active trials dedicated to sleep apnea research, this drug has also been featured in two previous studies since its initial listing in 2008. As researchers delve deeper into finding effective solutions for this common sleep disorder, acetazolamide shows potential in addressing the challenges faced by individuals suffering from sleep apnea. With further exploration and development, it could bring much-needed relief to those affected by this condition.
What are the most recent clinical trials for sleep apnea?
Recent clinical trials for sleep apnea offer promising advancements in the field. Oxygen plus supportive care (OXT) has shown potential benefits for patients with sleep apnea, with Phase 2 trials becoming available on 9/27/2023. Additionally, Atomoxetine-plus-Oxybutynin (AtoOxy) and Acetazolamide/Eszopiclone have exhibited positive results in Phase 1 and Phase 2 studies conducted as of September 2023. Another notable trial is Ato-oxy, which reached Phase 2 availability on 8/1/2023. Furthermore, a health communication message intervention study focusing on sleep apnea has progressed to Phases 1 and 2 since June 2023. These recent developments provide hope for improved treatment options and greater understanding of this complex condition affecting many individuals worldwide.
What sleep apnea clinical trials were recently completed?
Recently, there have been several notable clinical trials focused on sleep apnea that have reached completion. These studies represent significant advancements in the field and provide valuable insights into potential treatment options.